HCTZ
Sponsors
Novartis, Novartis Pharmaceuticals, Forest Laboratories, University of New Mexico, Boehringer Ingelheim
Conditions
AgingHealthyHigh Blood PressureHypertensionProteinuriaSedentary LifestyleType 2 Diabetes MellitusType II Diabetes
Early Phase 1
Phase 1
Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects
CompletedNCT02176512
Start: 1998-09-30Updated: 2014-07-08
Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers
CompletedNCT02262780
Start: 2003-12-01Updated: 2023-12-08
Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II
CompletedNCT02262858
Start: 2005-08-31Updated: 2014-10-13
Phase 2
Phase 3
Phase 4
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
CompletedNCT00277472
Start: 2005-11-30Updated: 2011-06-07
Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
CompletedNCT00425997
Start: 2006-12-31End: 2007-10-31Target: 480Updated: 2011-06-08
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
CompletedNCT00698646
Start: 2008-04-30End: 2009-06-30Updated: 2011-04-19
Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients
CompletedNCT00744237
Start: 2008-08-31Updated: 2011-07-29
The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function
CompletedNCT03115853
Start: 2009-06-30End: 2012-01-31Updated: 2017-08-25